Diamante
1 known investors
Diamante develops plant-based peptide drugs for immunotherapy, with an initial focus on rheumatoid arthritis treatment through immune re-education. The company produces therapeutics using plant biofactories, aiming to offer safer and more cost-effective alternatives to conventional immunosuppressive treatments.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Diamante do?
- Diamante develops plant-based peptide drugs for immunotherapy, with an initial focus on rheumatoid arthritis treatment through immune re-education. The company produces therapeutics using plant biofactories, aiming to offer safer and more cost-effective alternatives to conventional immunosuppressive treatments.
- Who are Diamante's investors?
- Diamante's investors include Angels4Women.